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There has recently been much advancement in the diagnosis, treatment, and research of metabolic
disorders, especially diabetes. Current research around the world is focused on ﬁnding an alternative
source of treatment from natural resources for diabetic management, apart from the available synthetic
medicines. The present study is a preliminary study of a polyherbal formulation using edible natural
resources and an assessment of its antidiabetic activity. The formulation was screened for its phyto-
chemical constituents, total phenols, ﬂavonoids, and vitamin C content. It was also analyzed for its
inhibitory effect against the digestive enzymes a-amylase and a-glucosidase, compared with the stan-
dard drug acarbose. The formulation showed the presence of major constituents such as steroids, cardiac
glycosides, phenols, ﬂavonoids, and saponins. It also had a high level of phenols (340 ± 2.5 mg/g), ﬂa-
vonoids (235.4 ± 8.3 mg/g), and vitamin C (470.8 ± 16.6 mg/g), and showed a half-maximal inhibitory
concentration (IC50) value of 0.41 ± 0.03 mg/mL and 0.51 ± 0.01 mg/mL for amylase and glucosidase,
respectively. The results showed that ADJ6 had a signiﬁcant inhibitory activity on a-amylase and a-
glucosidase; however, its inhibitory activity was less than that of acarbose. The plants that are formulated
in ADJ6 possess potent antidiabetic activity. Thus, we found that ADJ6 is a potent lead for effective
diabetic management; however, an evaluation of the formulation must be illustrated using an in vivo
model.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Type 2 diabetes or hyperglycemia, which is characterized by
high blood glucose levels and glycosuria, is an endocrine disorder. It
is responsible for the development of various other complications
in the human body. It may occur for two main reasons: (1) deﬁ-
cient/insufﬁcient secretion of insulin by the pancreatic beta cells1;
or (2) decreased or lost sensitivity of the insulin receptors.2 These
two factors are preceded by stress, obesity, and a sedentary life-
style.3,4 At present, diabetes management is a prime concern in theof Frontier Lifeline and Dr. K.
strial Estate Road, Mogappair,
obile).
umar).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).medical community. As a result of various factors, diabetes man-
agement is a challenging problem.5e8
However, many medicinal plants in ancient Indian Medicine
(Ayurveda) have been identiﬁed and used to reduce the hypergly-
cemic condition in the body. The herbs control the hyperglycemic
condition and effectively maintain normal glucose levels from a
long-term perspective. Many medicinal plants have recently been
evaluated for their antihyperglycemic property and have been
successfully proven for their effects.9e11 Numerous polyherbal
formulations are also being evaluated for effective diabetes man-
agement. However, none of the formulations has made signiﬁcant
inroads in treatment alternatives. Thus, a new formulation has been
developed that combines six different herbs that are used in daily
life as foods and have signiﬁcant antidiabetic activity. We combined
the six plants based on previously available literature, indigenous
knowledge, and various preliminary studies. Thus, the polyherbal
formulation has been named “ADJ6”. Our aimwas to investigate thersity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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prove its synergistic effect against various aspects involved in
diabetes management.
2. Materials and methods
2.1. Materials
Chemicals such as soluble starch and porcine pancreatic a-
amylase (PPA) were purchased from SRL Pvt. Ltd. (Mumbai, India).
a-Glucosidase, 3,5-dinitrosalicylicacid (DNSA), and 2,4-
dinitrophenyl hydrazine (DNPH) were obtained from HiMedia
Laboratories (Mumbai, India). Para-nitrophenyl a-D-glucopyrano-
side and standards such as gallic acid, quercetin, and ascorbic acid
were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).
Acarbose was purchased from Bayer Scientiﬁc (Leverkusen, Ger-
many). All other reagents and chemicals were of analytical grade
and procured locally in Chennai.
2.2. Identiﬁcation of plants
The herbs were collected from the medicinal farm Frontier
Mediville (Elavur, Gummidipoondi, India) and were submitted to
the Plant Anatomy Research Centre (Tamil Nadu, India) for
authentication. The authentication numbers have been provided in
an additional ﬁle 1. The plant names, families, and parts used and
their medicinal properties are listed in Table 1.
2.3. Preparation of ADJ6
The plant parts were minced individually using a mixer. The
individual plants were then freeze-dried using a lyophilizer to
minimize the loss of bioactive components. The freeze-dried
powder was stored in an air-tight container at room temperature
until further use. The traditional Ayurvedic methods of preparing
herbal formulations are primarily aqueous (it is likely that the
peptides, proteins and glycans possessing antidiabetic activity
would be denatured in organic solvents.). The powders of each
plant were mixed together in a speciﬁc proportion, soaked inwater
for 24 hours, and ﬁltered. The ﬁltrate was used for further analysis.
Fresh extracts were prepared when needed using the speciﬁc
proportion.
2.4. Pancreatic a-amylase inhibition assay
The inhibition assay was performed using the DNSA method.43
The assay mixture consisted of 500 mL of 0.02M sodiumTable 1
Plants and their parts used for the polyherbal formulation.
Serial
Number
Binomial name Common name Family name
1 Momordica charantia Bitter gourd Cucurbitaceae
2 Psidium guajava Guava Myrtaceae
3 Phyllanthus emblica Amla Phyllanthaceae
4 Trigonella foenum-graecum Fenugreek Fabaceae
5 Syzygium cumini Jamun Myrtaceae
6 Gymnema sylvestre Gymnema Asclepiadaceaephosphate buffer [containing 6mM sodium chloride (NaCl), pH 6.9],
0.05 units of PPA solution, and ADJ6 at a concentration of
0.1e1.5 mg/mL (w/v). The assay mixture was preincubated at 37C
for 20minutes. After incubation, 250 mL of 0.5% (v/v) starch solution
in the aforementioned buffer was added to the tubes and incubated
for 15minutes at 37C. The reactionwas terminated by adding 1mL
of dinitrosalicylic acid reagent and then incubated in a boiling
water bath for 10 minutes. The tubes were cooled and the absor-
bance was measured at 540 nm (Shimadzu UV-VIS 1800 spectro-
photometer; Shimadzu Corporation, Kyoto, Japan). A tube with PPA
but without ADJ6 served as the control with 100% enzyme activity.
Acarbose, an amylase inhibitor, was the positive control.
2.5. a-Glucosidase inhibition activity
The assay was performed with slight modiﬁcations using a-
glucosidase from Saccharomyces cerevisiae.44 The assay mixture
consisted of 150 mL of 0.1M sodium phosphate buffer (containing
6mM NaCl, pH 6.9), 0.1 unit of a-glucosidase, and ADJ6 at a con-
centration of 0.1e1.5 mg/mL (w/v). The assay mixture was pre-
incubated at 37C for 10 minutes. After incubation, 50 mL of 2mM
para-nitrophenyl a-D-glucopyranoside in 0.1M sodium phosphate
buffer was added to the mixture and incubated at 37C for 25 mi-
nutes. The reactionwas terminated by adding 50 mL of 0.1M sodium
carbonate (Na2CO3). The yellow color that developedwasmeasured
at 405 nm (Bio-Rad microplate reader; Bio-Rad Laboratories, Cali-
fornia, USA). The tube with a-glucosidase but without ADJ6 served
as the control with 100% enzyme activity, and acarbose served as
the positive control.
% Inhibition ¼ absorbance of control absorbance of extract
absorbance of control
 100
2.6. Qualitative phytochemical analysis
The formulation ADJ6 was analyzed for the presence of amino
acids, steroids, cardiac glycosides, phenols, tannins, terpenoids,
alkaloids, ﬂavonoids, saponins, carbohydrates, reducing sugar, and
anthrones.45
2.7. Evaluation of bioactive constituents
2.7.1. Estimation of total phenolic content
Total phenolic content was determined using gallic acid as the
reference standard.46 One milliliter of sample (0.2e1 mg/mL) wasPart used Activity Reference no.
Whole
fruit
Antihyperglycemic effect, analgesic,
antipyretic, hypotriglyceridemic,
hypocholesterolemic, antiulcerative,
antiproliferative, wound healing
12e19
Whole
fruit
Hypolipidaemic, hepatoprotective,
antihyperglycemic, renal protective,
antioxidant
20e24
Pulp Antihyperglycemic, hypolipidemic,
antiapoptotic, anti-inﬂammatory,
chondroprotective, endothelial dysfunction
25e29
Seeds Antihyperglycemic, neuroprotective,
immunomodulatory,
30e33
Seeds Antihyperglycemic, antiproliferative,
chemoprotective
34e38
Leaves Antihyperglycemic effect 15,39e42
Fig. 1. a-Amylase inhibition assay.
Fig. 2. a-Glucosidase inhibition assay.
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room temperature for 10minutes. Furthermore, 2.5 mL of saturated
Na2CO3 solution was added and incubated at room temperature for
30 minutes. The resultant color was measured at 750 nm versus a
blank containing distilled water and FolineCiocalteau reagent. To-
tal phenolic content was expressed in gallic acid equivalents using
the equation T ¼ CXV/M (T ¼ Total Phenolic Content (mg/g) of
extract as gallic acid equivalents, C ¼ Concentration of Gallic acid
established from the calibration curve, V ¼ Volume of the extract
solution in ml, M ¼ weight of extract in grams).
2.7.2. Determination of total ﬂavonoid content
Total ﬂavonoid content was determined with slight modiﬁca-
tions using quercetin as the reference standard.47 One milliliter of
sample (0.2e1 mg/mL) was added with 0.5 mL of 1.2% aluminum
chloride in 10% methanol, 0.5 mL of 1M potassium acetate, and
made up to 3 mL with distilled water. The mixture was incubated
for 30 minutes in the dark, and the absorbance was read at 415 nm.
Aluminum chloride without the sample alone served as the blank.
Total ﬂavonoid content was expressed in gram quercetin
equivalents.
2.7.3. Determination of vitamin C
Vitamin C was determined using the method described by
Roe,48 but with modiﬁcation, using ascorbic acid as the reference
compound. Fifty microliters of sample (0.2e1 mg/mL) was added
with 150 mL of 5% TCA (Trichloroacetic acid). The tubes were
centrifuged at 3500 g for 5 minutes. The mixture was added with
500 mL of 10mM DNPH and 500 mL of 4% thiourea and incubated at
room temperature for 3 hours. Postincubation 2.5 mL of 85% sul-
furic acid was added and the absorbance was measured at 530 nm.
The result was expressed in milligrams per gram of ascorbic acid.
2.8. Statistical analysis
All experiments were performed in three different sets with
each set duplicated. The data are expressed as the mean ± the
standard deviation (SD).
3. Results and discussion
3.1. Inhibition of a-amylase and a-glucosidase
a-Amylase (EC 3.2.1.1) randomly cleaves the a-(1e4) glycosidic
linkages of amylase to yield dextrin, maltose, or maltotriose,49
whereas a-glucosidase (EC 3.2.1.20) hydrolyzes the terminal
nonreducing 1-4 linked a-glucose to release glucose molecules.50
Incubation of the a-amylase with the substrate leads to the gen-
eration of maltose; however, the addition of the ADJ6 [inhibitory
effect (IC50), 0.41 ± 0.03 mg/mL) signiﬁcantly inhibited the libera-
tion of maltose in a dose-dependent manner, compared with
acarbose (IC50, 0.2 ± 0.01 mg/mL) (Fig. 1). The IC50 of a-glucosidase
was 0.51 ± 0.01 mg/mL, whereas that of acarbose was
0.39 ± 0.02 mg/mL (Fig. 2).
3.2. Phytochemical analysis
The aqueous extract of the formulation also showed the pres-
ence of major phytochemical constituents such as phenols, ﬂavo-
noids, steroids, cardiac glycosides, and saponins (Table 2).
3.3. Total phenol, ﬂavonoid, and vitamin C content
The aqueous extract of the formulation was estimated for total
phenol, ﬂavonoids, and vitamin C content. The amount of phenolswas 340 ± 2.5 mg/g equivalents of gallic acid. The amount of ﬂa-
vonoids was 235.4 ± 8.3 mg/g of quercetin equivalents, whereas the
level of vitamin C was the highest at 470.8 ± 16.6 mg/g of ascorbic
acid equivalents (Fig. 3).
The analyses suggested that the IC50 values of ADJ6 against a-
glucosidase and a-amylase at various concentrations were less than
those for the standard drug acarbose. Acarbose is a potent inhibitor
of a-amylase and a-glucosidase, but adverse effects have occurred
in the gastrointestinal tract because of excessive inhibition of the
amylase enzyme that results in ﬂatulence and diarrhea.51 Use of
acarbose for the treatment of diabetes by dietary control has
reportedly resulted in hepatitis.52e54 Acarbose treatment also ele-
vates liver enzyme levels, whereas its withdrawal normalizes
levels.55
There has recently been a push to ﬁnd an alternative source of
treatment for type 2 diabetes, especially frommedicinal plants that
have high potency and fewer adverse effects than preexisting
drugs.56e61 Excessive inhibition of pancreatic amylase can lead to
abnormal bacterial fermentation of carbohydrate foods in the co-
lon, which may lead to adverse digestive disorders.51,62 Plant-based
compounds and products derived from natural sources have been
reported for their potent inhibitory activities of the enzymes, but
have fewer or no side effects.56e61 The polyherbal formulation
ADJ6, although it has slightly less inhibitory activity than acarbose,
will likewise have fewer or no adverse effects because it is
completely derived from plant sources. Because ADJ6 is rich in
phytochemical constituents (i.e., phenols, ﬂavonoids, and vitamin
C), it will be helpful in the management of diabetes and will
Table 2
Phytochemical analysis.
Name of the constituent Inference
Amino acids 
Steroids þ
Cardiac Glycosides þ
Phenols þ
Tannins 
Terpenoids 
Alkaloids 
Flavonoids þ
Saponins þ
Carbohydrates 
Reducing sugar þ
Anthrones 
Fig. 3. Estimation of phenols, ﬂavonoids, and vitamin C.
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diabetes.
The present study elucidates that the polyherbal formulation
ADJ6 can be used for effectively managing type 2 diabetes mellitus.
The activities of the individual components of the plants are well
known for their insulin mimetic role and for their role in reducing
insulin resistance.
4. Conclusion
The plants that are used in the formulation have been long used
for food and medicinal purposes. Our results suggest that ADJ6
inhibits the enzymes a-amylase and a-glucosidase and contains a
high amount of phytochemical constituents (i.e., total phenols,
ﬂavonoids, and vitamin C). Thus, ADJ6 may be used in the man-
agement of type 2 diabetes mellitus with few or no side effects.
However, further studies of ADJ6 using in vitro and in vivo models
need to be performed to elucidate its insulin mimetic activity and
reduction of insulin resistance.
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